Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice

BACKGROUND/AIM: Danhong injection (DHI) is a Chinese patent drug used for relieving cardiovascular diseases. Recent studies have suggested that DNA methylation plays a pivotal role in the maintenance of cardiac fibrosis (CF) in cardiovascular diseases. This study was aimed at identifying the effect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oxid Med Cell Longev
Autors principals: Li, Sinai, Li, Ping, Liu, Weihong, Shang, Juju, Qiu, Shenglei, Li, Xiang, Liu, Wei, Shi, Haoyue, Zhou, Mingxue, Liu, Hongxu
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787771/
https://ncbi.nlm.nih.gov/pubmed/33456666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3158108
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars